Welcome to our dedicated page for PETVIVO HOLDINGS news (Ticker: PETV), a resource for investors and traders seeking the latest updates and insights on PETVIVO HOLDINGS stock.
PetVivo Holdings Inc (PETV) is an emerging biomedical device company with a focus on licensing and commercializing innovative medical devices for pets, known as pet therapeutics. The company aims to capitalize on investments in the human biomaterials and medical device industries to bring therapeutics to pets efficiently. As part of its strategy, PetVivo in-licenses proprietary products from human medical device companies for pet use. Its wholly-owned subsidiaries include PetVivo, Inc., Gel-Del Technologies, Inc., and CosmetaLife Corporation.
PetVivo Holdings, a biomedical device company focused on innovative therapeutics for pets, will present at the Aegis Capital Virtual Conference from May 2nd to 4th, 2023. CEO John Lai will discuss the company's Spryng product featuring OsteoCushion Technology, aimed at managing lameness and joint issues in companion animals.
Spryng is an injectable device that supports joint health by mimicking natural cartilage and is currently available for sale. The presentation is scheduled for May 3rd, 2023, from 12:25 PM to 12:55 PM ET. PetVivo holds a strong patent portfolio, with 17 products in development and a unique market strategy focused on veterinary devices.
PetVivo Holdings (NASDAQ: PETV, PETVW) has appointed Mary Grace Rutland as the new Business Development Manager for the Mid-Atlantic Region. Rutland, with 24 years of experience in animal health sales, will focus on promoting Spryng with OsteoCushion technology to veterinarians across the U.S. CEO John Lai expressed excitement about her addition, highlighting her previous roles in the industry, including positions at Fort Dodge Animal Health and Neogen Corporation. PetVivo specializes in innovative medical devices for companion animals, with Spryng aimed at treating lameness and joint-related conditions like osteoarthritis in dogs and horses. The company has a pipeline of 17 products and holds 19 patents covering its biomaterials and methods.
FAQ
What is the current stock price of PETVIVO HOLDINGS (PETV)?
What is the market cap of PETVIVO HOLDINGS (PETV)?
What is PetVivo Holdings Inc's focus?
How does PetVivo leverage investments in other industries?
What is PetVivo's strategy regarding proprietary products?
What are the wholly-owned subsidiaries of PetVivo Holdings Inc?
What is the goal of PetVivo Holdings Inc?
What industry does PetVivo Holdings Inc operate in?
How does PetVivo Holdings Inc differentiate itself in the market?
Where is PetVivo Holdings Inc headquartered?
What is the relationship between PetVivo Holdings Inc and Gel-Del Technologies, Inc?
What is the significance of CosmetaLife Corporation to PetVivo Holdings Inc?
